Clinical Guides

History Taking Clinical Guide

Structured patient interview protocol to elicit ocular, visual, systemic, and lifestyle information relevant to optometric diagnosis and management.

Last updated: March 2026

1. Clinical Importance

History taking is the foundation of every clinical encounter. In optometry, a thorough, structured history directs the entire examination — determining which tests to perform, which diagnoses to consider, and what management pathway is appropriate. Studies consistently show that an estimated 60–80% of diagnoses can be made on history alone, before any clinical test is performed.

Effective history taking in optometry extends well beyond “what brings you in today?”. It encompasses the patient's visual demands, ocular and systemic health background, medications (many of which directly affect the eyes), family risk, and the psychosocial context that shapes both clinical risk and patient expectations. A well-taken history prevents missed diagnoses, avoids unnecessary investigations, and builds the therapeutic relationship that drives patient adherence and satisfaction.

This guide presents history taking as a clinical skill — structured, systematic, and adaptable to every patient encounter from routine refraction to urgent ocular emergency.

History ComponentClinical PurposeKey Questions
Chief Complaint (CC)Identifies the primary reason for the visit; sets the examination agenda"What brings you in today?"
History of Presenting Complaint (HPC)Characterises the complaint fully; narrows differential diagnosisSOCRATES framework
Past Ocular History (POH)Identifies prior eye conditions, surgeries, and treatments affecting baseline findingsPrevious diagnoses, surgeries, spectacles/CLs
Past Medical History (PMH)Systemic diseases with ocular manifestations; contraindications to treatmentDiabetes, hypertension, autoimmune, thyroid
Medications & AllergiesOcular side effects; drug interactions; contraindicationsAll current medications including OTC, supplements
Family History (FH)Genetic risk for glaucoma, AMD, strabismus, high myopia, keratoconusFirst-degree relatives; eye conditions; glaucoma
Social & Occupational History (SH)Visual demands; driving status; occupational hazards; lifestyle risk factorsOccupation, driving, screen time, smoking, alcohol

2. Equipment and Tools

Tools & Materials

Essential

  • Patient health questionnaire or pre-visit intake form
  • Previous clinical records (if available)
  • Referral letters / specialist correspondence
  • Electronic health record (EHR) or paper record
  • Pen, notepad (for paper-based practices)
  • Interpreter (in-person or telephone) if required

Helpful Adjuncts

  • Standardised symptom questionnaires (e.g., NEI VFQ-25 for functional vision, OSDI for dry eye, CISS for convergence insufficiency)
  • Medication reference app (e.g., MIMS, BNF, Epocrates) for drug-ocular side effect lookup
  • Patient-facing diagrams / anatomical charts for explaining symptoms
  • Contact lens record card

3. Patient Preparation and Environment

Setting Up for an Effective History

  1. Review pre-visit information: Before entering the room, review any intake forms, previous records, or referral letters. Note the patient's age, existing diagnoses, and any flagged concerns. This prevents repetitive questioning and allows the history to build on existing knowledge.
  2. Introduce yourself: State your name and role. Confirm the patient's name and date of birth (two patient identifiers). In shared-care settings, clarify to the patient whether you are the primary clinician or part of a team.
  3. Ensure privacy: The consultation room should afford visual and acoustic privacy. Sensitive information — including driving concerns, mental health, or substance use — requires a private, unhurried environment.
  4. Minimise barriers: Sit at eye level with the patient. Avoid a desk as a physical barrier if possible. Maintain open body language. Put the computer screen to the side rather than between you and the patient.
  5. Establish the agenda: Ask the patient to list all concerns before beginning a detailed history of any one issue. "Before we start, is there anything else you'd like to talk about today?" — asked early, this prevents the “doorknob moment” where a second important concern emerges at the end of the appointment.
  6. Language and health literacy: Use plain language. Avoid jargon unless the patient demonstrates clinical familiarity. Adjust vocabulary to the patient's apparent health literacy. If English is not the patient's primary language, arrange a professional interpreter — do not rely on family members, especially children, for medical interpretation.

4. Core History-Taking Structure

Eliciting the Chief Complaint

The chief complaint is the patient's primary reason for attending — stated in their own words. It should be documented as a brief phrase, not a diagnosis. Open-ended questioning is essential at this stage.

Opening Questions (choose one)

  • “What brings you in today?”
  • “What can I help you with today?”
  • “What's been concerning you about your eyes/vision?”
  • “I can see from your form that you've noticed [symptom]. Can you tell me more about that?”

For Routine/Recall Visits

  • “You're here for your routine check — has anything changed with your vision or eyes since your last visit?”
  • “Any new concerns I should know about?”
  • “How have you been getting on with your current glasses/contact lenses?”

Common Chief Complaints in Optometry

Symptom CategoryExamplesKey Differentials to Consider
Blurred visionDistance blur, near blur, transient blur, variable blurRefractive error, cataract, AMD, diabetic macular oedema, dry eye, glaucoma
Flashes & floatersNew floaters, shower of floaters, flashing lightsPVD, retinal tear, retinal detachment, vitreous haemorrhage, migraine
Eye pain / discomfortAche, sharp pain, foreign body sensation, burning, grittinessDry eye, keratitis, uveitis, acute angle closure, scleritis, corneal abrasion
Red eyeUnilateral/bilateral, with/without discharge, painful/painlessConjunctivitis, episcleritis, scleritis, iritis, corneal ulcer, subconjunctival haemorrhage
Double visionMonocular vs binocular, horizontal vs vertical, constant vs intermittentDecompensated phoria, CN III/IV/VI palsy, thyroid eye disease, myasthenia
Visual field lossCentral scotoma, peripheral loss, hemianopia, altitudinal defectGlaucoma, AMD, stroke, NAION, retinal vascular occlusion
Discharge / tearingWatery, mucopurulent, mattering, overflow tearingConjunctivitis, blepharitis, nasolacrimal obstruction, ectropion
HeadacheBrow ache, frontal headache, associated with readingUncorrected refractive error, binocular vision disorder, acute angle closure, tension headache

5. Chief Complaint & History of Present Illness

Once the chief complaint is identified, use the SOCRATES framework to characterise it fully. This mnemonic — originally developed for pain history — translates excellently to ophthalmic symptom characterisation. Apply it to any symptom: blurred vision, floaters, pain, diplopia, or visual field loss.

S

Site

Which eye(s) are affected? Is it the whole visual field or a specific region?

  • “Is it in your right eye, left eye, or both?”
  • “Is the blurring in the centre of your vision, the sides, or all over?”
  • “Can you cover each eye and tell me if it's the same in both?”
  • Clinical note: Monocular vs binocular distinction is critical — monocular symptoms point to the eye/optic nerve; binocular symptoms suggest a post-chiasmal (brain) cause.
O

Onset

When did it start? Was it sudden or gradual?

  • “When did you first notice this?”
  • “Did it come on suddenly — like in seconds or minutes — or gradually over days or weeks?”
  • “What were you doing when you first noticed it?”
  • Clinical note: Sudden onset (seconds to minutes) = vascular emergency (occlusion, detachment, GCA). Gradual onset (weeks to months) = degenerative, refractive, or chronic inflammatory. Intermittent transient loss = TIA, amaurosis fugax, papilloedema, angle closure.
C

Character

What does the symptom feel or look like?

  • “How would you describe the blurring — is it like looking through frosted glass, a smear, or a dark patch?”
  • “Is the pain sharp and stabbing, dull and aching, or more of a burning sensation?”
  • “Are the floaters like dots, cobwebs, a curtain, or moving shadows?”
  • “Is the double vision side-by-side, one above the other, or diagonal?”
R

Radiation / Associations

Does the symptom spread or associate with other symptoms?

  • “Does the pain go anywhere — into your forehead, temple, or jaw?”
  • “Do you have any other symptoms alongside it — headache, nausea, sensitivity to light, a runny nose?”
  • “Have you noticed any facial drooping, weakness, or numbness?”
  • Clinical note: Jaw claudication with headache and visual symptoms in patients >50 = GCA until proven otherwise. Facial pain + red eye + photophobia = uveitis or keratitis.
A

Alleviating & Aggravating Factors

What makes it better or worse?

  • “Does anything make it better — like blinking, closing one eye, or wearing your glasses?”
  • “Does anything make it worse — bright light, reading, being tired, the end of the day?”
  • “Is it better in the morning and worse at night, or the opposite?”
  • Clinical note: Dry eye symptoms worst at end of day, in air conditioning, and with screen use. Binocular vision symptoms worse with near work and fatigue. Corneal oedema worse in the morning (overnight accumulation). Angle closure worse in dim light or after prolonged reading (pupil dilation).
T

Time Course

Is it constant, intermittent, progressive, or resolving?

  • “Is it there all the time, or does it come and go?”
  • “Is it getting better, worse, or staying the same?”
  • “How long does each episode last?”
  • Clinical note: Transient visual loss lasting seconds = papilloedema (positional), TIA, or amaurosis fugax. Lasting minutes = migraine aura. Lasting hours = intermittent angle closure.
E

Exacerbating Factors & Effect on Daily Life

How is this affecting the patient's functioning and quality of life?

  • “How much is this affecting your daily life — work, driving, reading?”
  • “Are you able to drive safely with this symptom?”
  • “On a scale of 0 to 10, how much does this bother you?”
  • Clinical note: Functional impact guides urgency of management and also helps set patient expectations for treatment outcomes. For chronic conditions (AMD, glaucoma), functional impact drives referral and rehabilitation decisions.
S

Severity & Prior Treatment

Has the patient sought any prior treatment? What was tried and what happened?

  • “Have you seen anyone else about this before?”
  • “Have you tried any eye drops, warm compresses, or other treatments?”
  • “Were you prescribed anything for this? Did it help?”
  • Clinical note: Prior treatment history reveals treatment failures (may need escalation), ongoing prescriptions (check compliance and current drop regimen), and prior test results relevant to the current presentation.

6. Ocular History

Key Areas to Cover

  1. Previous spectacles and contact lenses: Current prescription (near, distance, progressive, multifocal)? Satisfaction? When last changed? Contact lens type, modality, wear pattern, cleaning system, compliance with replacement schedule. Any contact lens-related complications?
  2. Previous ocular diagnoses: Amblyopia, strabismus, glaucoma, macular degeneration, diabetic retinopathy, uveitis, corneal disease, retinal detachment. When diagnosed? Under whose care? What treatment or monitoring is in place?
  3. Ocular surgery: Cataract extraction (IOL type: monofocal, multifocal, toric), refractive surgery (LASIK, SMILE, PRK — when, which eye, any complications), trabeculectomy, vitreoretinal surgery, strabismus surgery, lid procedures. Note: LASIK significantly affects IOP measurement accuracy and IOL calculation if cataract surgery is subsequently required.
  4. Amblyopia and strabismus: History of patching? Orthoptic treatment? Was strabismus surgically corrected? What is the current alignment and binocular status?
  5. Trauma: Any previous eye injury? Type (chemical, blunt, penetrating, foreign body)? Was it treated? Any residual effects (scarring, reduced vision, lid abnormality)?
  6. Ocular medications: Current and recent topical drops — IOP-lowering agents, steroid drops, antivirals, antibiotics, lubricants. Duration of use? Compliance? Any side effects? Topical steroids should prompt IOP monitoring; long-term use of certain drops (brimonidine) may cause allergic conjunctivitis.

Spectacle & Contact Lens History — Useful Questions

Spectacles

  • “Do you wear glasses or contact lenses?”
  • “Are they for distance, reading, or both?”
  • “How long ago were they last prescribed?”
  • “Are you happy with them — are they clear and comfortable?”
  • “Do you always wear them, or only for certain tasks?”

Contact Lenses

  • “What type of lenses — daily, fortnightly, monthly?”
  • “How many hours a day do you wear them?”
  • “Do you sleep in them?”
  • “What solution do you use to clean them?”
  • “Any redness, pain, or blurring with your lenses in?”

7. Systemic & Medical History

Systemic disease is the most common cause of vision-threatening ocular complications encountered in primary care optometry. A thorough systemic history is not a formality — it directly shapes examination priorities, test selection, diagnosis, co-management, and referral decisions.

Systemic Conditions with Major Ocular Relevance

Systemic ConditionOcular ManifestationsOptometric Action
Diabetes mellitus (Type 1 & 2)Diabetic retinopathy, DMO, cataract, cranial nerve palsy, fluctuating refraction, rubeosisDilated fundus exam; grading per ETDRS; co-management with diabetic eye screening programme
HypertensionHypertensive retinopathy, retinal vascular occlusion, NAIONFundus examination; document Keith-Wagener-Barker grading; refer if uncontrolled or undiagnosed
Multiple sclerosis (MS)Optic neuritis (painful unilateral visual loss, RAPD), internuclear ophthalmoplegia, nystagmusOCT RNFL (retrograde axonal loss); colour vision; urgent neurology referral for new presentation
Rheumatoid arthritis (RA)Dry eye (secondary Sjögren's), scleritis, episcleritis, peripheral ulcerative keratitisOcular surface assessment; hydroxychloroquine screening if applicable
Systemic lupus erythematosus (SLE)Dry eye, keratoconjunctivitis sicca, retinal vasculitis, hydroxychloroquine maculopathyAnnual hydroxychloroquine retinal toxicity screening (OCT, 10-2 HVF, mfERG)
Thyroid disease (Graves' / Hashimoto's)Thyroid eye disease (TED): proptosis, lid retraction, restricted motility, exposure keratopathy, compressive optic neuropathyExophthalmometry; colour vision; OCT; urgent ophthalmology if optic neuropathy suspected
HIV / immunosuppressionCMV retinitis, toxoplasma retinochoroiditis, herpes zoster ophthalmicus, fungal endophthalmitisDilated fundus exam; urgent referral if active infection suspected
Sickle cell diseaseProliferative sickle retinopathy, sea-fan neovascularisation, vitreous haemorrhageDilated fundus + peripheral retina; ophthalmology co-management
Hypertension + atherosclerosisCentral/branch retinal artery occlusion (CRAO, BRAO); embolic diseaseCRAO = ocular emergency; refer within hours. Review carotid/cardiac risk.
Neurofibromatosis type 1 (NF1)Lisch nodules (iris hamartomas), optic pathway glioma, plexiform neurofibroma of lidSlit lamp iris examination; OCT; refer to ophthalmology if optic glioma suspected

Key Systemic History Questions

  • “Do you have any medical conditions I should know about?”
  • “Have you been diagnosed with diabetes? If so, Type 1 or 2? How long ago? How is it controlled — diet, tablets, or insulin?”
  • “Do you have high blood pressure? Is it being treated? What is your most recent reading?”
  • “Have you ever been told you have high cholesterol or cardiovascular disease?”
  • “Have you ever had a stroke or TIA?”
  • “Do you have any autoimmune or inflammatory conditions — arthritis, lupus, thyroid disease, inflammatory bowel disease, psoriasis?”
  • “Have you had any neurological conditions — MS, Parkinson's, epilepsy?”
  • “Have you had any serious infections or are you immunocompromised?”
  • “Have you had any cancer or chemotherapy?”

8. Medications & Allergies

Eliciting a Medication History

Ask about all medications: prescription, over-the-counter, herbal, supplement, and topical. Many patients do not consider non-prescription items as “medications.” Specific prompting is required.

  1. “Are you taking any prescribed medications at the moment — tablets, injections, patches, inhalers?”
  2. “Are you using any eye drops — whether prescribed or over the counter?”
  3. “Are you taking any vitamins, supplements, or herbal remedies?”
  4. “Do you use any nasal sprays or skin creams regularly?” (Topical corticosteroids can raise IOP.)
  5. “Have you had any steroid injections recently?”
  6. “Are you on any blood thinners such as aspirin, warfarin, or newer agents like apixaban or rivaroxaban?”

Drugs with Significant Ocular Side Effects

Drug / ClassOcular Side EffectOptometric Monitoring
Hydroxychloroquine (Plaquenil)Bull's-eye maculopathy (retinal toxicity); irreversibleAnnual screening from year 5: OCT macula, 10-2 HVF, mfERG (AAO guidelines). Baseline before treatment.
Corticosteroids (topical, systemic, inhaled, nasal)Posterior subcapsular cataract (PSC); steroid-induced ocular hypertensionIOP monitoring; lens assessment; annual eye exams for long-term users
AmiodaroneCorneal verticillata (vortex keratopathy); optic neuropathy (rare but vision-threatening)Slit lamp; colour vision; OCT; refer if optic neuropathy suspected
TamoxifenCrystalline macular deposits; macular oedema; optic neuritis (rare)Annual OCT macula monitoring for patients on long-term tamoxifen
Ethambutol (TB treatment)Optic neuropathy — bilateral, central scotoma, colour vision lossBaseline then monthly colour vision and visual acuity monitoring
Vigabatrin (antiepileptic)Permanent, irreversible binasal visual field lossRegular visual field testing; ophthalmology co-monitoring
Isotretinoin (Roaccutane)Dry eye; blepharitis; reduced contrast sensitivity; night vision disturbance; benign intracranial hypertension (rare)Ocular surface assessment; disc evaluation if papilloedema suspected
Topiramate (antiepileptic / migraine)Acute myopia + bilateral angle closure (idiosyncratic; within weeks of starting)Alert for new acute myopia — treat as angle closure emergency
Alpha-1 blockers (tamsulosin, alfuzosin)Intraoperative floppy iris syndrome (IFIS) — risk during cataract surgeryDocument use and alert surgeon before any planned cataract surgery
Sildenafil / PDE5 inhibitorsTransient colour vision disturbance (blue tinge); non-arteritic AION (rare); serous retinal detachment (rare)Advise caution with NAION risk factors; colour vision enquiry if symptomatic

Allergies

  • Ask about all allergies: drug, topical, contact, environmental, food. Record the specific substance and the nature of the reaction (rash, anaphylaxis, intolerance).
  • Local anaesthetic allergy: Relevant if GAT or other contact procedures are planned. Consider rebound tonometry (iCare) or NCT as alternatives.
  • Fluorescein allergy (rare): Systemic fluorescein angiography carries more risk than topical fluorescein; document if reported. Topical fluorescein allergy is very uncommon but document if stated.
  • Contact allergy: Nickel, thiomersal (formerly used in contact lens solutions), benzalkonium chloride (BAK — preservative in many topical drops) — relevant for contact lens wearers and patients on long-term topical medications.
  • Eye drop preservative sensitivity: Many patients report “sensitivity” to drops without true allergy. BAK-preserved drops can cause significant ocular surface toxicity with long-term use. Consider preservative-free formulations for glaucoma patients on multiple drops.

9. Family & Social History

A. Family History

Why Family History Matters in Eye Care

Many common and vision-threatening eye conditions have strong heritable components. Family history is a significant independent risk factor for several conditions and should be explicitly elicited — patients often do not volunteer this information unless asked directly.

ConditionInheritance PatternRisk Increase with FHOptometric Implication
Glaucoma (POAG)Polygenic; complex~10× higher risk in first-degree relativesLower referral threshold; full glaucoma workup including CCT, OCT, VF
Age-related macular degeneration (AMD)Polygenic (CFH, ARMS2 variants)~3–4× higher riskEarlier and more frequent monitoring; lifestyle advice (smoking cessation, diet, AREDS2 supplements)
KeratoconusAutosomal dominant (variable penetrance)~15–67× higher riskCorneal topography / Scheimpflug imaging for siblings and children of affected patients
High myopiaPolygenic; strong parental effectUp to 6–8× higher with two myopic parentsEarlier myopia management intervention; educate parents on risk; outdoor time advice
Strabismus / amblyopiaPolygenic~4× higher in first-degree relativesEarly cover test and stereopsis assessment in children of affected parents
Retinitis pigmentosa (RP)AD, AR, or X-linked depending on typeHigh familial clusteringGenetic counselling referral; electrodiagnostic testing
Diabetes mellitusComplex; strong familial clustering (T2DM)~2–6× higher riskFasting glucose enquiry; systematic screening of diabetic complications

Key Questions

  • “Is there any history of eye disease in your family — parents, brothers, sisters, or children?”
  • “Has anyone in your family been diagnosed with glaucoma or had blind spots in their vision?”
  • “Has anyone in your family had macular degeneration or lost central vision as they got older?”
  • “Is there any family history of blindness or significant visual loss?”
  • “Do any close family members have diabetes or heart disease?”
  • “Do any family members wear very strong glasses or have high short-sightedness?” (for myopia management)

B. Social & Occupational History

Occupation & Visual Demands

Occupation directly determines what level of visual performance is required and what occupational hazards may be present. It is essential for appropriate optical correction and advice.

  • “What do you do for work?” — follow up with details about visual tasks (screen work, precision work, outdoor work, driving)
  • “How many hours a day do you spend on screens or near work?”
  • “Is your work indoors or outdoors? Are you exposed to dust, chemicals, UV light, or other hazards?”
  • “Do you need specific vision requirements for your job — such as a commercial driving licence, aviation, or fine detail work?”
  • Safety eyewear: Patients working with machinery, chemicals, or projectiles should be advised on appropriate occupational eye protection (AS/NZS 1337, EN166, ANSI Z87.1 standards depending on jurisdiction).

Driving

Visual fitness to drive is a legal and ethical obligation. Different jurisdictions define visual standards for private and commercial driving licences. Optometrists have a professional and, in many countries, legal duty to advise patients when their vision does not meet the applicable driving standard.

Country / RegionPrivate Driving Standard (approx.)Commercial / HGV Standard
UK (DVLA)6/12 Snellen binocular; VF >120° horizontal (Group 1)6/7.5 each eye; 6/7.5 binocular; VF >160° (Group 2)
Australia (Austroads)6/12 binocular best-corrected (Class 1)6/9 each eye; 6/6 binocular (Class 2/3)
USA (varies by state)Typically 20/40 binocular or better-seeing eyeFMCSA: 20/40 each eye (corrected); full VF; no monocular vision for commercial
EU (Directive 2006/126/EC)0.5 (6/12) binocular; VF 120° horizontal (Group 1)0.8 (6/7.5) both eyes; 0.1 each eye (Group 2)
Singapore / Malaysia6/12 binocular with correction6/6 binocular with correction for commercial

Always check current national driving authority guidelines — standards are updated periodically and vary for conditions such as monocularity, diplopia, visual field loss, and colour vision deficiency. Document your driving advice and any notification obligation in the clinical record.

Lifestyle Risk Factors

Smoking

  • Current / ex-smoker? Pack-years?
  • Smoking is the single largest modifiable risk factor for AMD (2–4× increased risk).
  • Also associated with increased risk of cataracts, diabetic retinopathy progression, thyroid eye disease severity, and NAION.
  • Offer cessation advice and signpost to national quit services.

Alcohol

  • Heavy alcohol use is associated with toxic optic neuropathy, nutritional deficiencies (B12, folate) causing optic neuropathy, and increased cataract risk.
  • Use a non-judgmental opener: “Do you drink alcohol at all?”

Screen Time & Digital Device Use

  • Total daily screen hours; device distance; lighting conditions.
  • Digital eye strain (asthenopia): symptoms of blur, headache, dry eye, neck pain.
  • Myopia risk in children: extended near work + limited outdoor time (particularly in East Asian populations).

UV Exposure & Outdoor Activity

  • Chronic UV exposure increases cataract (particularly nuclear) and pterygium risk.
  • Outdoor time is protective against myopia onset and progression in children.
  • Advise UV-blocking sunglasses and hat use for high-exposure individuals.

10. Review of Systems

A brief targeted review of systems ensures that relevant symptoms not raised in the chief complaint are captured. In optometry, this means a systematic scan for symptoms across all visual and adnexal structures. Not every question is asked at every visit — tailor the review to the presenting complaint and the patient's risk profile.

System / StructureKey QuestionsRelevant Diagnoses to Consider
Visual acuityAny difficulty seeing clearly at distance or near? Night vision problems?Refractive error, cataract, glaucoma, AMD
Visual fieldAny areas of missing vision? Peripheral vision concerns?Glaucoma, retinal detachment, stroke, NAION
Colour visionAny change in the brightness or colour of objects? Colours look washed out?Optic neuropathy, AMD, drug toxicity (HCQ, ethambutol)
Lids & periorbitalDrooping eyelid? Lumps, bumps, or skin changes around the eyes?Ptosis (3rd nerve palsy, Horner's), chalazion, BCC, SCC, DES
Conjunctiva / scleraAny redness, discharge, or yellowing of the whites of the eyes?Conjunctivitis, jaundice, scleritis, episcleritis
CorneaSensitivity to light? Foreign body sensation? Cloudy or hazy vision?Keratitis, corneal dystrophy, recurrent erosion, dry eye
LensAny halo around lights at night? Difficulty with glare?Cataract, posterior capsule opacification
Vitreous / retinaFloaters, flashing lights, curtain across vision, distortion?PVD, retinal tear, RD, ARMD, epiretinal membrane
Binocular vision / motilityDouble vision, difficulty reading for prolonged periods, words moving on the page?Decompensated phoria, CI, CN palsy, thyroid eye disease
Systemic / neurologicalHeadaches, jaw pain, scalp tenderness, facial numbness, arm/leg weakness?GCA, raised ICP, MS, TIA, stroke

11. Red Flags & Urgent Referrals

A. Red Flag Symptoms — Urgent / Emergency Action Required

The following symptoms, when identified in the chief complaint or history, require immediate triage and same-day or emergency referral:

  • Sudden, painless loss of vision (monocular): Retinal artery/vein occlusion, vitreous haemorrhage, retinal detachment, NAION — same-day ophthalmology referral.
  • Sudden visual loss with headache + jaw claudication + scalp tenderness in patient >50: Giant cell arteritis (GCA) — same-day systemic corticosteroids + emergency referral. Do not delay.
  • Shower of new floaters ± flashes ± curtain/shadow across vision: Presumed retinal tear or detachment — urgent same-day ophthalmology referral.
  • Painful red eye + halos around lights + nausea/vomiting: Suspect acute angle-closure glaucoma — immediate emergency referral.
  • Diplopia of sudden onset in adult with no prior history of strabismus: CN palsy, posterior communicating artery aneurysm, MS — urgent neurology/ophthalmology referral same day.
  • Eye trauma (chemical, penetrating, blunt): Chemical — immediate irrigation before referral. Penetrating — shield and immediate transfer. Blunt with reduced vision — same day.
  • Transient monocular visual loss (amaurosis fugax): Carotid or cardiac embolic event — same-day medical referral; treat as TIA.

B. Paediatric Patients

  • History from carer and child: Obtain history primarily from the parent or carer, but also engage the child directly — even young children can describe symptoms in their own words. Always address the child, not just the accompanying adult.
  • Birth and developmental history: Gestational age (prematurity → ROP risk), birth weight, birth complications, developmental milestones — particularly motor and language delay (associated with amblyopia and binocular vision problems).
  • School performance: Difficulty reading? Sitting close to the board? Avoiding near tasks? Headaches after schoolwork? These are red flags for undetected refractive error, amblyopia, or convergence insufficiency.
  • Strabismus: “Does your child's eye ever turn or look in a different direction?” “Did any family members have a lazy eye or squint as a child?”
  • Myopia risk assessment: Time spent outdoors per day (<2 hours is a risk factor); screen time; parental myopia. Key for early myopia management intervention decisions.
  • Safeguarding awareness: Non-accidental injury (NAI) can present with ocular findings. Be alert to inconsistent histories, unexplained periorbital bruising, retinal haemorrhages in infants. Follow local child safeguarding protocols if concerned.

C. Elderly Patients

  • Falls risk: Visual impairment is a major risk factor for falls in older adults. Ask about recent falls, difficulty with steps or kerbs, and reduced confidence in low-light environments. Refer to falls prevention services where appropriate.
  • Polypharmacy: Patients over 65 may be taking multiple medications with ocular side effects. A systematic medication review is particularly important in this age group. Ask about recent medication changes.
  • Cognitive impairment: Patients with dementia may not reliably report symptoms or medication history. Involve the accompanying carer. Cognitive impairment itself can affect visual processing — rule out ocular causes before attributing visual complaints to cognition.
  • Low vision and functional assessment: For patients with established visual impairment, assess functional impact: reading, face recognition, mobility, independence with daily tasks, emotional wellbeing. Refer to low vision services and community support organisations.
  • GCA awareness: Any patient over 50 presenting with sudden visual loss, headache, jaw claudication, scalp tenderness, or raised inflammatory markers — suspect giant cell arteritis immediately. Do not defer — same-day referral and treatment.

D. Pregnant & Breastfeeding Patients

  • Refractive changes: Fluid retention and hormonal changes during pregnancy can transiently alter corneal shape and refractive error. Advise against ordering new spectacles until after delivery and cessation of breastfeeding unless the change is significant.
  • Pre-eclampsia: Can cause visual symptoms — flashing lights, blurred vision, diplopia. Any pregnant patient with these symptoms and raised blood pressure requires urgent obstetric review.
  • Drug safety: Many topical ophthalmic agents are category C or D in pregnancy. Minimise topical anaesthetic use; avoid unnecessary dilation. If mydriatics must be used, nasolacrimal occlusion reduces systemic absorption.
  • Contact lenses: Some patients notice contact lens intolerance during pregnancy due to corneal changes and dry eye. Reassure and consider temporary spectacle wear.
  • Diabetic retinopathy: Pre-existing DR can worsen significantly during pregnancy. Ensure diabetic patients are in a pregnancy-specific diabetic eye screening pathway.

Quick Reference Protocol

  1. Review pre-visit information and establish the consultation agenda early.
  2. Elicit the chief complaint in the patient's own words using open-ended questions.
  3. Characterise symptoms with a structured framework (SOCRATES) and assess functional impact.
  4. Take ocular, systemic, medication/allergy, family, and social/occupational history systematically.
  5. Perform a targeted review of systems and screen for urgent red-flag features.
  6. Document contemporaneously, including key negatives, driving advice, and clear management/referral actions.

Documentation and Communication

Essential Clinical Documentation

  • Record contemporaneously: Document history findings at the time of the consultation, not retrospectively. Contemporaneous records are more accurate and carry greater medicolegal weight.
  • Use the patient's own words for the chief complaint: Record the CC verbatim in quotation marks where possible — “blurry reading for 2 weeks” rather than “reduced near VA.” This preserves clinical accuracy and is medicolegally important.
  • Negative findings matter: Explicitly document pertinent negatives — “No flashes, no floaters, no headache” is clinically meaningful if the patient later presents with these symptoms.
  • Drug allergies must be prominently displayed: Document all allergies at the top of the record, flagged clearly. Incorrect or absent allergy documentation is a significant source of adverse events.
  • Record driving advice: If you advise a patient they do not meet the legal driving standard, document this explicitly: “Advised patient that current VA does not meet the [DVLA Group 1 / Austroads / state] standard. Advised to cease driving until further assessment/correction.”
  • GDPR / privacy compliance: In the UK, EU, Australia, and many other jurisdictions, patient records are subject to data protection legislation. Records must be kept securely, retained for the required period (typically 7–10 years for adults; longer for children), and provided to patients upon request.

Patient and Family Communication

  • Use plain language: Avoid jargon unless the patient demonstrates clinical familiarity, and adjust vocabulary to health literacy.
  • Confirm all concerns early: Ask whether there is anything else the patient wants addressed to avoid late-emerging concerns.
  • Address ideas, concerns, and expectations: Explore what the patient thinks is happening, what worries them most, and what outcome they expect.
  • Communicate legal advice clearly: Explain and document driving advice where visual standards are not met.
  • Involve carers when needed: Especially for children, elderly patients, and patients with cognitive impairment or language barriers.

DATE: 21/02/2026    TIME: 10:30    CLINICIAN: [Name]

CC: “Blurry vision at distance — worse over last 3 months”

HPC: 3/12 Hx gradual bilateral distance blur, L>R. No diplopia. No flashes/floaters. No headache. Worse at end of working day. Computer use ~8 hrs/day. Improves slightly with squinting.

POH: Prev myope; last Rx 2022 (-2.25/-0.50 × 180 R, -2.75/-0.25 × 175 L). No surgery. No ocular Hx.

PMH: Nil significant. No DM. No hypertension.

Meds: Nil regular. OTC: multivitamins.

Allergies: NKDA. No topical anaesthetic allergy recorded.

FH: Father — glaucoma (diagnosed age 62, on drops). Mother — myope. No AMD, no KC.

SH: Software developer. Drives (private). Non-smoker. Occasional alcohol. Cat owner (relevant for dry eye).

ROS: No colour change. No VF symptoms. No diplopia. No systemic Sx.

12. Clinical Pearls & Best Practices

Pearl #1: Establish the Agenda Before the History

Before diving into the chief complaint, ask: “Is there anything else you'd like to discuss today?”Studies show that unelicited concerns raised at the end of a consultation take longer to address and are more likely to be left unresolved. Agenda setting at the start makes consultations more efficient and patients more satisfied.

Pearl #2: Sudden = Emergency Until Proven Otherwise

Any symptom described as “sudden” onset — vision loss, floaters, diplopia, eye pain — must be triaged for emergency pathology before a routine history proceeds. The initial triage question is the most important clinical decision point in the consultation. Sudden painless monocular visual loss requires same-day ophthalmology contact regardless of any other finding.

Pearl #3: Ask Specifically About Steroids

Patients rarely volunteer corticosteroid use unless directly asked. Ask specifically about nasal sprays, skin creams applied near the eyes, inhaled steroids, systemic courses, and injections. Steroid-induced IOP elevation and posterior subcapsular cataract are common and preventable sequelae of undisclosed steroid use. Unexplained elevated IOP or PSC cataract in a younger patient should always prompt a steroid drug history.

Pearl #4: The Monocular vs Binocular Test

For any visual complaint, always establish whether the symptom is monocular or binocular by asking the patient to cover each eye alternately. Monocular symptoms localise to the eye or optic nerve on the same side. Binocular symptoms that persist when either eye is covered suggest a post-chiasmal (neurological) cause. This single question can redirect the entire examination and referral pathway.

Pearl #5: Time Is Tissue in Vascular Events

For retinal artery occlusion, stroke, and GCA, delays of even hours significantly worsen outcomes. For GCA specifically, visual loss in the fellow eye can occur within days or hours of the first eye — high-dose systemic corticosteroids must be commenced before histological confirmation is obtained. Do not wait for ESR / CRP results before commencing treatment if clinical suspicion is high.

Pearl #6: The Family History Changes the Examination

A positive family history of glaucoma in a first-degree relative should prompt a full glaucoma workup — IOP, CCT, disc assessment, OCT RNFL, and visual fields — regardless of the presenting complaint. The same patient presenting for a “routine check” should be examined more thoroughly than one without this history. Let the history direct the examination, not the appointment type.

Pearl #7: Ask About Hydroxychloroquine at Every Rheumatology Patient Visit

Hydroxychloroquine (HCQ) maculopathy is dose-dependent, cumulative, and irreversible. Annual screening is recommended from year 5 of treatment (or earlier in high-risk patients). Many patients taking HCQ for RA, SLE, or lupus are not on a formal screening pathway. Optometrists in primary care are uniquely positioned to initiate and coordinate this screening. Always confirm current dose (target ≤5 mg/kg/day based on real body weight) and duration.

Pearl #8: ICE — Ideas, Concerns & Expectations

Beyond the clinical history, understanding the patient's Ideas (what they think is causing their symptoms), Concerns (what worries them most — “Is it something serious?”), and Expectations (what they hope to get from the visit) dramatically improves clinical communication, adherence, and satisfaction. A patient convinced their blur is a sign of cancer will not be reassured by a new spectacle prescription until their fear has been acknowledged and addressed.

Pearl #9: Ask About Driving in Every Patient

“Do you drive?” is a mandatory history question — not an optional one. Patients with visual acuity below the legal driving standard, significant visual field loss, or conditions affecting visual processing (diplopia, severe dry eye in harsh conditions, medication-related vision effects) must be advised clearly and the advice documented. In most jurisdictions, optometrists have a duty to advise — and in some, a statutory reporting obligation.

Pearl #10: Use Silence Effectively

After asking an open-ended question, resist the urge to fill silence immediately. Patients often need 3–5 seconds to formulate their response. Premature interjection with closed questions shifts control of the narrative to the clinician and often causes the patient to withhold important information. Research shows that patients who are not interrupted in the first 30 seconds rarely speak for more than 1–2 minutes — and almost always provide diagnostically critical information.

Golden Rule of History Taking

“Listen to your patient — they are telling you the diagnosis.” — Sir William Osler. The history is not a checklist to be completed before the “real” examination begins. It IS the examination. An optometrist who takes a careful, structured, empathic history will make fewer mistakes, order more targeted tests, provide better patient care, and be a more effective advocate for their patients' systemic and ocular health — than one who rushes to the slit lamp.

References

  1. Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach, 8th ed. Edinburgh: Elsevier; 2016.
  2. Hampton JR, Harrison MJG, Mitchell JRA, Prichard JS, Seymour C. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. BMJ. 1975;2(5969):486–489.
  3. Silverman J, Kurtz S, Draper J. Skills for Communicating with Patients, 3rd ed. London: CRC Press; 2013.
  4. Neighbour R. The Inner Consultation: How to Develop an Effective and Intuitive Consulting Style, 2nd ed. Oxford: Radcliffe Publishing; 2004.
  5. College of Optometrists. Clinical Management Guidelines. London: College of Optometrists; 2024. Available at: https://www.college-optometrists.org/clinical-guidance
  6. Marmamula S, Ravilla TD, Bhojwani DN, Khanna RC. History taking and case recording in community eye care. Community Eye Health. 2013;26(82):27–29.
  7. Myles Optometry. Optometric history and symptoms forms. In: Clinical Optometry, 2nd ed. Butterworth-Heinemann; 2001.
  8. Macular Society / AMD Alliance. Age-related macular degeneration: risk factors and family history guidance. 2023. Available at: https://www.macularsociety.org
  9. Hogg RE, Chakravarthy U. AMD and micronutrient antioxidants. Curr Eye Res. 2004;29(6):387–401.
  10. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453–1460.
  11. Marmor MF, Kellner U, Lai TYY, et al. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology. 2016;123(6):1386–1394.
  12. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714–720.
  13. DVLA. Assessing fitness to drive: a guide for medical professionals. Swansea: Driver and Vehicle Licensing Agency; 2024. Available at: https://www.gov.uk/guidance/assessing-fitness-to-drive-a-guide-for-medical-professionals
  14. Austroads. Assessing fitness to drive for commercial and private vehicle drivers: medical standards for licensing and clinical management guidelines. Sydney: Austroads; 2022.
  15. Hayreh SS. Giant cell arteritis: its ophthalmic manifestations. Indian J Ophthalmol. 2021;69(8):1888–1909.
  16. Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005;25(5):381–391.
  17. Gifford KL, Richdale K, Kang P, et al. IMI – Clinical management guidelines report. Invest Ophthalmol Vis Sci. 2019;60(3):M184–M203.
  18. Ang M, Flanagan JL, Wong CW, et al. Review: myopia control strategies recommendations from the 2018 WHO Asia-Pacific Myopia Summit. Br J Ophthalmol. 2020;104(10):1343–1347.
  19. NHS England. Enhanced service specification: ophthalmology referral refinement and community services. London: NHS England; 2023.
  20. World Health Organization. Universal Eye Health: A Global Action Plan 2014–2019. Geneva: WHO; 2013.